Kian Behbakht

9.2k citations

127 papers · 3.9k indexed · h-index 34

Impact in

Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
Obstetrics and Gynecology top 1%
- Endometrial and Cervical Cancer Treatments

Papers in

Reproductive Medicine 48
- Ovarian cancer diagnosis and treatment 46
Obstetrics and Gynecology 35
- Endometrial and Cervical Cancer Treatments 30
- Uterine Myomas and Treatments 12

Co-authors: Stephen C. Rubin Andrew Thorburn Heide L. Ford Benjamin G. Bitler Ivor Benjamin Jeff Boyd Zachary L. Watson Virginia A. LiVolsi
Journals: Gynecologic Oncology (39 papers)Journal of Clinical Oncology (6 papers)International Journal of Gynecological Cancer (6 papers)Molecular Cancer Research (5 papers)Obstetrics and Gynecology (5 papers)
Partner nations: United States United Kingdom Denmark

In The Last Decade

Kian Behbakht

118 papers receiving 3.8k citations

Peers

Countries citing papers authored by Kian Behbakht

Since Specialization

Citations

This map shows the geographic impact of Kian Behbakht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kian Behbakht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kian Behbakht more than expected).

Fields of papers citing papers by Kian Behbakht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kian Behbakht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kian Behbakht. The network helps show where Kian Behbakht may publish in the future.

Co-authors

The 25 scholars most cited alongside Kian Behbakht, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kian Behbakht Line = papers co-authored together Kian Behbakht links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Feasibility of assessing symptoms associated with ovarian cancer using an electronic medical intake questionnaire Gynecologic Oncology Reports ·善明柳沼, Cam Nguyen, Т. Л. Жукова, Saketh R. Guntupalli, Barbara A. Goff, Benjamin G. Bitler, Kian Behbakht	2025	1
2	Claudin-4 Stabilizes the Genome via Nuclear and Cell-Cycle Remodeling to Support Ovarian Cancer Cell Survival Cancer Research Communications ·Marshall W. Carter, Julie Lang, Siti Hafizah Suaidi, Kian Behbakht, Mar�a In�s Vera, Patricia Webb, Kenneth P. Nephew, Margaret Neville, Elizabeth R. Woodruff, Benjamin G. Bitler	2024	3
3	EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell–Dependent Manner Molecular Cancer Research ·Lily L. Nguyen, Zachary L. Watson, Raquel Ortega, Elizabeth R. Woodruff, Kimberly R. Jordan, Ritsuko Iwanaga, Tomomi M. Yamamoto, 河村英文, 高宏井上, Christian Berger, Marshall W. Carter, 殷允健, Saketh R. Guntupalli, Kian Behbakht, Veronica Gibaja, Nausica Arnoult, Edward B. Chuong, Benjamin G. Bitler	2024	0
4	Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation Molecular Cancer Therapeutics ·Lily L. Nguyen, Zachary L. Watson, Raquel Ortega, Elizabeth R. Woodruff, Kimberly R. Jordan, Ritsuko Iwanaga, Tomomi M. Yamamoto, 河村英文, 高宏井上, 殷允健, Saketh R. Guntupalli, Kian Behbakht, Veronica Gibaja, Nausica Arnoult, Alexis Cocozaki, Edward B. Chuong, Benjamin G. Bitler	2024	3
5	The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma Cancer Immunology Research ·Zachariah L. Jett, 邦枝松岡, (unknown), Rebecca J. Wolsky, Christian Rickert, Kimberly R. Jordan, Junxiao Hu, Jennifer K. Richer, Lindsay W. Brubaker, Nicole A. Marjon, Kian Behbakht, Matthew J. Sikora, Benjamin G. Bitler, Aaron Clauset	2024	2
6	A phase II, randomized, double-blind study of the use of rucaparib versus placebo maintenance therapy in metastatic and recurrent endometrial cancer Gynecologic Oncology ·Bradley R. Corr, Ashley Haggerty, Stefan Gysler, Sarah E. Taylor, Kian Behbakht, Bob Blackmur, Carolyn Lefkowits, Lindsay W. Brubaker, Voron, Friedrich Knilli, nicolas JAOUEN, Junxiao Hu, Saketh R. Guntupalli	2024	0
7	Systematic review: Early ovarian cancer detection in the age of fallopian tube precursors Gynecologic Oncology ·Melles Haile Aman, Kian Behbakht, Elizabeth R. Woodruff, Benjamin G. Bitler	2024	0
8	Loss of Claudin-4 Reduces DNA Damage Repair and Increases Sensitivity to PARP Inhibitors Molecular Cancer Therapeutics ·Tomomi M. Yamamoto, Patricia Webb, Dana M. Davis, Heidi K. Baumgartner, Elizabeth R. Woodruff, Saketh R. Guntupalli, Margaret Neville, Kian Behbakht, Benjamin G. Bitler	2022	11
9	ATF6-Mediated Signaling Contributes to PARP Inhibitor Resistance in Ovarian Cancer Molecular Cancer Research ·Alexandra McMellen, Tomomi M. Yamamoto, Lubna Qamar, Emine Tuğba Alataş, Lily L. Nguyen, Constança Júnior, Jr . John W. Davison, H R MALLOY, (unknown), Joshua Johnson, Kian Behbakht, Ana Cervera Segura, Edward B. Chuong, Benjamin G. Bitler	2022	17
10	PARPi after PARPi in epithelial ovarian cancer Gynecologic Oncology Reports ·C. Lucchinetti, Kian Behbakht, Tiffany Lai, I. A. Sadkovskii, D.M Cino, Josef Dvořák, Kai Ding, Gottfried E. Konecny, Kathleen N. Moore	2021	21
11	The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval Clinical Cancer Research ·Kimberly R. Jordan, Matthew J. Sikora, Jill E. Slansky, Christoph M. Volz, Jennifer K. Richer, G Giomataris, Junxiao Hu, Rebecca J. Wolsky, Zachary L. Watson, Tomomi M. Yamamoto, James C. Costello, Aaron Clauset, Kian Behbakht, S. Mavinamne, Benjamin G. Bitler	2020	40
12	Targeting Fatty Acid Oxidation to Promote Anoikis and Inhibit Ovarian Cancer Progression Molecular Cancer Research ·Austin Dada, Lubna Qamar, Tomomi M. Yamamoto, Alexandra McMellen, Zachary L. Watson, Jennifer K. Richer, Kian Behbakht, Isabel R. Schlaepfer, Benjamin G. Bitler	2020	86
13	Ovarian Tumor Cell Expression of Claudin-4 Reduces Apoptotic Response to Paclitaxel Molecular Cancer Research ·Apri Cahyo Diwantoro, Douglas A. Hicks, Patricia Webb, D H Allison, Benjamin G. Bitler, Kian Behbakht, Heidi K. Baumgartner	2019	22
14	Amplification of the Mutation-Carrying BRCA2 Allele Promotes RAD51 Loading and PARP Inhibitor Resistance in the Absence of Reversion Mutations Molecular Cancer Therapeutics ·Pyoung Hwa Park, Tomomi M. Yamamoto, Hua Li, Allen L. Alcivar, Bing Xia, Yifan Wang, Andrea J. Bernhardy, Kristen M. Turner, Andrew V. Kossenkov, Zachary L. Watson, Kian Behbakht, Silvia Casadei, Elizabeth M. Swisher, Paul S. Mischel, Neil Johnson, Benjamin G. Bitler	2019	20
15	Activation of Wnt signaling promotes olaparib resistant ovarian cancer Molecular Carcinogenesis ·Tomomi M. Yamamoto, Alexandra McMellen, Zachary L. Watson, 和宏樫尾, Susan Holland, Elmar Nurmemmedov, Tanay Thakar, George‐Lucian Moldovan, Hyunmin Kim, Diana M. Cittelly, 俊介小野, 周吉平山, Kai Pu, Kian Behbakht, Matthew J. Sikora, Benjamin G. Bitler	2019	74
16	A Genome-Wide Loss-of-Function Screen Identifies SLC26A2 as a Novel Mediator of TRAIL Resistance Molecular Cancer Research ·Lina Y. Dimberg, Christina G. Towers, Kian Behbakht, Edward J. Van Lierr, Jihye Kim, Susan Fosmire, Christopher C. Porter, Aik Choon Tan, Andrew Thorburn, Heide L. Ford	2017	6
17	A method for extracting and characterizing RNA from urine: For downstream PCR and RNAseq analysis Analytical Biochemistry ·Paige Newell, Monique A. Spillman, Kian Behbakht, Andrew W.Robertson, Juan E. Abrahante, Douglas A. Hicks, P. F. W., Alina Bari, Kenneth L. Jones, Michael W. Graner, Lynne Bemis	2017	7
18	Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia Obstetrics and Gynecology ·Raymond Osborne, Virginia L. Filiaci, Julian C. Schink, Robert S. Mannel, Kian Behbakht, James Hoffman, Nick M. Spirtos, John K. Chan, John Tidy, David S. Miller	2016	41
19	Distinct TRAIL Resistance Mechanisms Can Be Overcome by Proteasome Inhibition but not Generally by Synergizing Agents Cancer Research ·力渋谷, Lianghua Bin, Jacqueline Thorburn, Kian Behbakht, Heide L. Ford, Andrew Thorburn	2011	27
20	Six1 Overexpression in Ovarian Carcinoma Causes Resistance to TRAIL-Mediated Apoptosis and Is Associated with Poor Survival Cancer Research ·Kian Behbakht, Lubna Qamar, Johnny Chin Fui Chung, Ricardo D. Coletta, Susan A. Davidson, Andrew Thorburn, Heide L. Ford	2007	148

About Kian Behbakht

Kian Behbakht is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Oncology, Cancer Research and Internal Medicine, having authored 127 papers that have together received 3.9k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (46 papers), Endometrial and Cervical Cancer Treatments (30 papers), PARP inhibition in cancer therapy (15 papers), Uterine Myomas and Treatments (12 papers), Cancer-related Molecular Pathways (9 papers), BRCA gene mutations in cancer (8 papers), Cervical Cancer and HPV Research (7 papers) and Cancer Cells and Metastasis (7 papers). The work is most often cited by research in Reproductive Medicine (1.1k citations), Obstetrics and Gynecology (584 citations), Cancer Research (693 citations), Oncology (1.2k citations) and Genetics (753 citations). Kian Behbakht has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include Stephen C. Rubin, Andrew Thorburn, Heide L. Ford, Benjamin G. Bitler, Ivor Benjamin, Jeff Boyd, Zachary L. Watson, Virginia A. LiVolsi, Mark A. Morgan and Lindsay W. Brubaker. Their work appears in journals such as Gynecologic Oncology, Journal of Clinical Oncology, International Journal of Gynecological Cancer, Molecular Cancer Research and Obstetrics and Gynecology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact